P2Y1 Receptor as a Catalyst of Brain Neurodegeneration
Different brain disorders display distinctive etiologies and pathogenic mechanisms. However, they also share pathogenic events. One event systematically occurring in different brain disorders, both acute and chronic, is the increase of the extracellular ATP levels. Accordingly, several P2 (ATP/ADP)...
Main Authors: | Ricardo J. Rodrigues, Ana S. Figueira, Joana M. Marques |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | NeuroSci |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4087/3/4/43 |
Similar Items
-
P2Y Receptors in Bone - Anabolic, Catabolic, or Both?
by: Yuhan Zhou, et al.
Published: (2022-01-01) -
Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity
by: Milka Koupenova, et al.
Published: (2018-01-01) -
Brain cortical injury induces changes in peripheral lymphocyte ectonucleotidase activities
by: Laketa Danijela, et al.
Published: (2013-01-01) -
P2Y12 Receptor Antagonist Clopidogrel Attenuates Lung Inflammation Triggered by Silica Particles
by: Patricia Teixeira Santana, et al.
Published: (2020-03-01) -
P2Y12 Receptors in Tumorigenesis and Metastasis
by: Patrizia Ballerini, et al.
Published: (2018-02-01)